Loading...

Home
ETF
TARA

TARA

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

TARA News

Protara Therapeutics Reports Q4 2025 Financial Results

Mar 10 2026seekingalpha

JP Morgan Initiates Protara with Overweight Rating

Mar 04 2026seekingalpha

Latest Ratings and Price Targets on Wall Street

Mar 04 2026CNBC

Protara Therapeutics Reports Interim Data for TARA-002 in Bladder Cancer Trial

Feb 24 2026seekingalpha

Protara Therapeutics Updates TARA-002 Trial Results

Feb 24 2026Benzinga

Keysight Technologies Quarterly Earnings Beat Estimates

Feb 24 2026Benzinga

Protara's Bladder Cancer Trial Shows Strong Efficacy

Feb 24 2026stocktwits

Protara Updates on TARA-002 Clinical Trial Results

Feb 23 2026Newsfilter

ScinoPharm Secures FDA Approval for Glatiramer Acetate Injection in Multiple Sclerosis

Jan 09 2026NASDAQ.COM

Protara Doses First Patient in Pivotal THRIVE-3 Trial for IV Choline Chloride

Jan 07 2026NASDAQ.COM

Protara Therapeutics Receives FDA Breakthrough and Fast Track Designations for TARA-002

Jan 05 2026Globenewswire

Protara Closes $75 Million Public Offering of 13 Million Shares

Dec 08 2025Globenewswire

Protara Therapeutics Closes $75 Million Public Offering of 13 Million Shares

Dec 08 2025Newsfilter

Protara Secures $75 Million Funding to Support TARA-002 and Expand Pipeline Development

Dec 05 2025NASDAQ.COM

Protara Therapeutics Stock Drops 16% Following $75 Million Public Offering

Dec 05 2025NASDAQ.COM

Ulta Beauty Stock Rises Approximately 6%; Check Out 20 Stocks Making Moves in Premarket Trading

Dec 05 2025Benzinga